What Happened?
Los Angeles, CA-based Puma Biotechnology Appointed Alan Auerbach as Chief Executive Officer, President
About the Company
We focus on in-licensing innovative drug candidates that are undergoing or have already completed initial clinical testing for the treatment of various forms of cancer and then seek to further develop these drug candidates for commercial use.
About the Person
Alan Auerbach is Chief Executive Officer, President at Puma Biotechnology. Previously, Alan held various senior HR leadership roles in the industry.
Info Source
News
Short Profile